Skip to content

Effect of Patent Hemostatic Device (PHD) With Quantitative Pressure on Radial Artery Hemostasis After CAG/PCI

Effect of Patent Hemostatic Device (PHD) With Quantitative Pressure on Radial Artery Hemostasis After CAG/PCI:a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05790603
Acronym
PCI
Enrollment
200
Registered
2023-03-30
Start date
2024-05-21
Completion date
2024-12-31
Last updated
2024-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemostasis, Percutaneous Coronary Intervention

Keywords

Percutaneous coronary intervention, Radial artery hemostasis, Quantitative pressure, Randomized controlled trial

Brief summary

The objective of this clinical trial is to compare the hemostatic effect of 2 hemostatic devices with or without quantitative pressure on radial arteries after coronary angiography (CAG) or percutaneous coronary intervention (PCI). The main questions aims to answer: * What is the hemostatic effect of the patent hemostatic device with quantitative pressure after percutaneous coronary intervention? * What are the precise hemostatic pressure and hemostatic time of the radial artery after CAG/PCI? Participants will be randomly assigned to the intervention group (IG) and control group (CG). The IG will use patent hemostatic device with quantitative pressure (PHDQP-Band, China) while the CG will use the conventional radial artery hemostatic device (TR-Band, Japan) without pressure monitoring. The primary outcomes is incidence of 24h radial artery occlusion (24h RAO). Secondary outcomes include time to hemostasis, bleeding, hematoma, 30d radial artery occlusion (30d RAO), pain, hand swelling, numberness, pseudoaneurysm, and radial artery stenosis.

Detailed description

The objective of this clinical trial is to compare the hemostatic effect of 2 hemostatic devices with or without quantitative pressure on radial arteries after percutaneous coronary intervention. The main questions aims to answer: * What is the hemostatic effect of the patent hemostatic device after percutaneous coronary intervention? * What are the precise hemostasis pressure and hemostasis time of the radial artery after percutaneous coronary intervention? Participants will be randomly assigned to the intervention group (IG) and control group (CG). For the participants assigned to the IG, the radial systolic pressure will be measured after TRA procedure. The PHD-Band with quantitative pressure ( WEGO Medical Products Group CO. LTD, China) will be placed at the entry site of the sheath. Connecting the hemostatic devices to the electric pneumatic machine with a connecting cable. After removing the radial sheath, the puncture site will be compressed by operator's hand. The PHD-Band with quantitative pressure will be inflated with specific pressure radial systolic pressure plus 10mmHg) and the hand will slowly release the pressure. If bleeding occurs, the PHD-Band will be deflated with 5-10mmHg automatically by parameter setting with the electric pneumatic machine until the bleeding stops. The PHD-Band will be deflated with20 mmHg, 40 mmHg of decreased pressure following 1h and 2h after the procedure. After 3 hours, the hemostatic pressure will be released to 45mmHg and the PHD-Band will be removed if no bleeding occurs. If rebleeding occurs, the band will be inflated according to the previous pressure for another an hour until bleeding stops. For the participants assigned to the CG, the TR-Band (Terumo Medical Corporation, Japan) will be placed at the entry site of the sheath after TRA procedure and inflated with 10 mL of air and the radial sheath will be removed with hand compression. Another 5 mL of air will be inflated and the operator's hand will slowly release the pressure. The TR band will be inflated until bleeding stopped with the maximum air volume no more than 18ml. The band will be deflated with 1 mL of air hourly for the following 2 hours after the procedure. After 3 hours, the band will be deflated with 4 mL of air first and then all volume of the rest air if no bleeding occurs and then the band will be removed if no bleeding occurs. If rebleeding occurs, the band will be inflated with 1 mL of air until bleeding stops . For all enrolled participants, the investigators will record the complications such as bleeding, subcutaneous hematoma, pain, hand swelling, numbness, pseudoaneurysm after the operation. Radial artery occlusion, subcutaneous hematoma, pseudoaneurysm, and radial artery stenosis were confirmed by arterial ultrasound within 24 hours and 30 days after surgery.

Interventions

DEVICEIntervention group with PHD-Band

The initial compression pressure was systolic blood pressure plus 10mmHg. Pressure will be released by 20mmHg and 40mmHg 1 hour and 2 hours respectively after the surgery and then the band will be removed after 3 hours if no bleeding occurs. The compression will continue if bleeding occurs.

DEVICEControl group with TR-Band

TR-Band will be inflated with 15 mL of air The band will be deflated with 1 mL of air hourly for the following 2 hours after the procedure. After 3 hours, the band will be removed if no bleeding occurs. If rebleeding occurs, the band will be inflated with appropriate volume of air until bleeding stops .

Sponsors

Xuanwu Hospital, Beijing
CollaboratorOTHER
Peking University First Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

One of the primary outcome of radial artery occlusion will be assessed by masking the assessor. The data analyzers will also be blinded.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Patients undergoing coronary angiography or percutaneous coronary intervention via the radial artery; Positive Allen's test result; Willing to sign informed consent.

Exclusion criteria

Radial artery malformation; Chronic kidney disease with eGFR\<30ml/min.1.73m2; Cirrhosis of the liver; Coagulation disfunction; Patients treated with IIb / IIIa receptor antagonist.

Design outcomes

Primary

MeasureTime frameDescription
Incidence early radial artery occlusionWithin 24 hours after CAG/PCIRAO occurs within 24 hours after CAG/PCI

Secondary

MeasureTime frameDescription
Incidence of access site bleedingWithin 24 hours after CAG/PCIAccess site bleeding within 24 hours after CAG/PCI
Incidence of hematomathrough hemostasis completion,estimated to be an average of 4~6hoursThe incidence of subcutaneous hematoma in the distal skin of the compression site 24 h after the removal of the compression device
Incidence of 30d radial artery occlusionWithin 30 days after CAG/PCIRAO occurs within 30 days after CAG/PCI
Compression timethrough hemostasis completion,estimated to be an average of 3~6hoursThe interval from the time of sheath removal to the time of hemostasis removal
numbnessbaseline; 24 hours after PCINumbness level is classified as no numbness with 0, mild numbness: 1\ 2; moderate numbness: 3; severe numbness:4\ 5
Hand swellingbaseline; 24 hours after PCIThe circumference diameter of both hands was measured using a tape gauge contrast.
pseudoaneurysmWithin 24 hours after PCIIt refers to the lumen of the same as the artery formed by the blood through the perivascular tissue after arterial puncture.
The degree of painbaseline; 24 hours after PCIPain level is classified as painless: 0; mild pain: 1\ 3; moderate pain: 4\ 6; severe pain: 7\ 10.

Countries

China

Contacts

Primary ContactZhenhui Tao
terry1018china@163.com+8613811839842

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026